Could that be (at least partially) explained by those companies looking at a long-term treatment as the more realistic goal after being burned by proposed cures in the past? Lots of quacks out there offer a quick cure, not as many say up front that their product will need a prolonged period of use. Not saying you and yours fit that label but their bullshit tips the signal-to-noise ratio in an unfavorable direction for both relief-seekers and providers.
I don’t know your field, team’s reputation or the companies you’ve been in contact with though so of course it could be the simple greed motivation too.
It started as an Xtracab but was downgraded to cab.